BACKGROUND: Emergence of HIV-1 drug resistance may limit the sustained benefits of
antiretroviral therapy (ART) in settings with limited laboratory monitoring and drug options …

Abstract In this study we report the prevalence of antiretroviral drug resistant HIV-1
genotypes of virus isolated from Djiboutian patients who failed first-line antiretroviral therapy …

Antiretroviral therapy (ART) and drug resistance studies worldwide have focused almost
exclusively on human immunodeficiency virus type 1 (HIV-1). As a result, there is limited …

Introduction Antiretroviral therapy (ART) in resource-limited settings has expanded in the last
decade, reaching> 8 million individuals and reducing AIDS mortality and morbidity …

Background Despite a substantial reduction in virological failures following introduction of
new potent antiretroviral therapies in the latest years, drug resistance remains a limitation for …

A large cohort of 220 HIV-1-infected children (median [range] age: 12 [4–17] years) was
cared and followed up in the Central African Republic, including 198 in 1st-line and 22 in …

Low-frequency mutations associated with drug resistance have been related to virologic
failure in subjects with no history of pre-treatment and recent HIV diagnosis. In total, 78 …

Background Better understanding of drug resistance patterns in HIV-infected children on
antiretroviral therapy (ART) is required to inform public health policies in high prevalence …

Background. After the scale-up of antiretroviral therapy (ART) for human immunodeficiency
virus (HIV) infection in Africa, increasing numbers of patients have pretreatment drug …

An estimated 1.5 million Kenyans are HIV-seropositive, with 1.1 million on antiretroviral
therapy (ART), with the majority of them unaware of their drug resistance status. In this study …